IT & Informatics

Complete Genomics Service Targets $1000 Genome by Spring 2009

10/10/2008

Bio-IT World | Complete Genomics emerged from stealth mode today brandishing an audacious service model for wholesale next-generation sequencing, with its first human genome already assembled and the CEO’s pledge to reach the magical “$1000 genome” price point as early as spring 2009.

DNA Nanoballs, Petabytes of Data Mark Complete Genomics Platform

10/6/2008

Bio-IT World | With the unveiling today of the next phase of the next-generation sequencing era by Complete Genomics comes intense scrutiny of the sequencing-by-hybridization strategy that the company says will deliver one million genome sequences in the next five years

IO Informatics Puts Semantic Web Ideas to Work

7/9/2008

Bio-IT World | The founders of IO Informatics adopted semantic web ideas early and incorporated them into a scientific data integration and management platform: Sentient Suite.

Phase 5 of the Cancer Gene Index Project Begins

6/26/2008

Bio-IT World | Sophic has announced $1.3 million of funding from the National Cancer Institute to complete the Cancer Gene Index Project over the next 12 months. Sophic started the project in June 2004 with the goal of mining 8.8 million Medline abstracts to identify suspected cancer genes and manually annotate gene-disease and gene-compound relationships.

GTA4: Enabler of Life Sciences Research?

5/29/2008

Bio-IT World | The huge success of a game like GTA4 will lead electronics makers to develop even better graphics and faster animation, which are increasingly being tapped to conduct life sciences R&D.

AI Improves Automated High-Throughput Screening

5/29/2008

Bio-IT World | Researchers have applied an artificial intelligence (AI) technique to cellular image analysis that has the potential to significantly speed up a method for analyzing biological specimens.

GNS: Building a SNPs-to-Outcomes Engine

4/17/2008

Bio-IT World | Interview with Gene Network Sciences CEO Colin Hill, on sifting through the genetic data flood to accurately predict SNPs-to-outcomes.

James Watson’s Personal Genome Published in Nature

4/16/2008

Bio-IT World | Fifty-five years after James Watson co-authored the most famous paper in Nature magazine’s history -- the discovery of the DNA double helix with Francis Crick -- his genome sequence is also gracing the pages of the famous scientific journal.

Al Gore Helps Navigenics Launch Personal Genomics Service

4/10/2008

Bio-IT World | Former Vice President Al Gore’s surprise appearance was the highlight of the Tuesday reception that marked the launch of Navigenics’ new personal genomics service.

NIH Laptop Theft: How Safe Is Your Data?

3/26/2008

Bio-IT World | A laptop stolen from the NIH included seven years’ worth of clinical trial data, including names, medical diagnoses, and details of the patients' heart scans.

Dealing with the Data Deluge: Three Things IT Should Do

3/26/2008

Bio-IT World | The life sciences are undergoing an unprecedented data explosion, according to new research released this month by IDC.

Applied Biosystems and the $60,000 Human Genome

3/13/2008

Bio-IT World | Just weeks after Illumina announced it had cracked the $100,000 threshold for sequencing a human genome, Applied Biosystems has sequenced a complete human genome sample using its new SOLiD next-generation sequencing platform, reportedly for less than $60,000.

Helicos' Kristen Stoops on Next-Generation Data Management

3/12/2008

Bio-IT World | Interview with Kristen Stoops, Helicos' director of bioinformatics, who is building a federation of IT vendors to identify best practices that will help users manage torrents of data.

MIT Launches Interdisciplinary Cancer Center

3/7/2008

Bio-IT World | The David H. Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology opened today in Cambridge, and will replace the previous MIT Center for Cancer Research.

BlueArc Doubles Titan Storage to Four Petabytes

3/4/2008

Bio-IT World | San Jose-based BlueArc has unveiled a new top-of-the-line product for its Titan range that could find a dynamic market in the life sciences and pharma communities.